Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.06
+0.32 (3.66%)
Nov 19, 2026, 4:00 PM EST - Market closed
Adlai Nortye Group Market Cap
Adlai Nortye Group has a market cap or net worth of $583.45 million as of November 19, 2026. It is the 12,822nd most valuable company in the world and the 2,551st biggest in the United States. Its market cap has increased by 907.10% in one year.
Market Cap
583.45M
Enterprise Value
377.33M
1-Year Change
907.10%
Global Rank
Country Rank
#2,551 United States
Category
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye Group's market cap has increased from $553.50M to $583.45M, an increase of 5.41%. That is a compound annual growth rate of 1.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 583.45M | 1,013.48% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 (IPO) | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geron | 644.24M |
| Bicara Therapeutics | 637.32M |
| Olema Oncology | 632.52M |
| Design Therapeutics | 630.12M |
| Alumis | 628.33M |
| DBV Technologies | 624.05M |
| Arbutus Biopharma | 620.84M |
| 4D Molecular Therapeutics | 608.33M |